HSITP and Pfizer Hong Kong Forge Strategic Partnership

We are delighted to share that on April 30, our CEO, Mr. Vincent Ma, and Mr. Krish Sundaresan, General Manager, Pfizer Hong Kong and Macau, came together at the Hong Kong Park in the Loop to sign a Memorandum of Understanding (MoU), marking the beginning of an exciting strategic partnership! 
 
Honourable guests including Mr. Lv Feng, Deputy Director-General of the Economic Affairs Department, Liaison Office of the Central People's Government in the HKSAR (LOCPG); Mr. Peter Yan, JP, Director-General of Office for Attracting Strategic Enterprises; Mr. Wang Dan Feng, Director of the Economic Affairs Department, Liaison Office of the LOCPG; Professor Bernard Cheung, Chief Executive Officer, Greater Bay Area International Clinical Trial Institute; and Mr. Jim Zeng, Regional Director, Greater Bay Area and Central China, Hong Kong Trade Development Council, have graced the occasion.
 
Prior to the MoU signing ceremony, our esteemed guests enjoyed a guided tour of the HSITP Show Suite and Building 11, our state-of-the-art talent accommodation, where they gained deeper insights into the development plans of the Hong Kong Park in the Loop, setting the stage for a shared understanding of the transformative potential of our collaboration.
 
This strategic partnership is a powerful step forward in our shared vision to establish the Hong Kong Park as the region’s preeminent hub for biotech talent development and clinical trials. By uniting the unique strengths and expertise of HSITPL and Pfizer Hong Kong, we are poised to deliver advancements that will shape the progression of the biotechnology sector in the region.